G-H-3 International Inc. (GHTI) is a publicly traded company in the Healthcare sector, operating within the Medical - Pharmaceuticals industry. The company is headquartered in Las Vegas, United States. The current CEO is Flo Ternes.
GHTI has IPO date of 2023-06-05, listed on the Other OTC.
G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body. Its product, G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treat chronic disease, and improve health and vitality. The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products. The company was formerly known as The Chelsea Collection, Inc. and changed its name to G-H-3 International Inc. G-H-3 International, Inc. is based in Las Vegas, Nevada.
